Algrofin (Crizotinib INN 250mg Capsule) is indicated for the treatment of patients with locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) that is Anaplastic Lymphoma Kinase (ALK)-positive.

Algrofin (Crizotinib INN 250 mg Capsule) is also Standard treatment for patients with Anaplastic Lymphoma Kinase (ALK) in metastatic Non-Small Cell Lung Cancer (NSCLC).